首页 | 本学科首页   官方微博 | 高级检索  
     

健择联合顺铂方案治疗晚期胰腺癌的疗效观察
引用本文:李平,王雅杰,李兆申. 健择联合顺铂方案治疗晚期胰腺癌的疗效观察[J]. 中华肿瘤防治杂志, 2002, 9(3): 291-292
作者姓名:李平  王雅杰  李兆申
作者单位:1. 上海第二军医大学附属长海医院肿瘤科,上海,200433
2. 上海第二军医大学附属长海医院消化内科,上海,200433
摘    要:目的 :观察GP (健择 DDP)方案治疗晚期胰腺癌的近期疗效与不良反应。方法 :将 2 0例晚期胰腺癌给予GP方案化疗 2个周期 ,按WHO标准评定疗效和不良反应。结果 :有效率 (CR PR)为35 % ,不良反应主要为骨髓抑制和胃肠道反应。结论 :健择加顺铂是治疗晚期胰腺癌的一种安全有效的化疗方案。

关 键 词:胰腺肿瘤/药物疗法  药物疗法  联合  健择/投药和剂量  顺铂/投药和剂量
文章编号:1009-4571(2002)03-0291-02
修稿时间:2001-11-28

Clinical Observasion of Gemcitabine Plus Cisplatin in the Treatment of Advanced Pancreatic Cancer
LI Ping,WANG Ya-jie,LI Zhao-shen. Clinical Observasion of Gemcitabine Plus Cisplatin in the Treatment of Advanced Pancreatic Cancer[J]. Chinese Journal of Cancer Prevention and Treatment, 2002, 9(3): 291-292
Authors:LI Ping  WANG Ya-jie  LI Zhao-shen
Affiliation:LI Ping,WANG Ya-jie,LI Zhao-shen.Department of Oncology,Changhai Hospital,Shanghai 200433,China
Abstract:Objective To observe the efficacy and toxicity of Gemcitabine plus cisplatin for advanced pancreatic cancer.Methods The clinical data of 20 case with advanced pancreatic cancer treated with GP regimen were analysed.Results The response rate was 35%.The main toxicity was myelosuppression and gastrointestinal tract reaction.Conclusion Gemcitabine plus cisplatin is an effective and safe chemotherapeutic protocol for the treatment of advanced pancreatic cancer.
Keywords:pancreatic neoplasms/drng therapy  drug therapy combination  gemcitabine/drug and dosage  cisplatin/drug and dosage
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号